By Femtech Insider News, Newsletter February 16, 2023 ShareTwitterFacebookPinterest-circled What’s New in Femtech This Week? (Feb 16, 2023)
By Femtech Insider News, Reproductive Health February 15, 2023 ShareTwitterFacebookPinterest-circled On-Demand Male Contraceptive Developed by Weill Cornell Medicine Shows Promise in Preclinical Study
By Femtech Insider Menopause, News, Partnership February 15, 2023 ShareTwitterFacebookPinterest-circled Lifepoint Health and Midi Health Collaborate to Provide Virtual Care to US Women Going Through Menopause
By Femtech Insider Medical Device, Menopause, News February 15, 2023 ShareTwitterFacebookPinterest-circled Madorra’s Device Could Offer a New, Nonhormonal Treatment Option for Post-Menopausal Women with Vaginal Atrophy
By Femtech Insider Investment, News, Reproductive Health February 14, 2023 ShareTwitterFacebookPinterest-circled Natural Cycles Raises $7M Strategic Investment from Samsung Ventures
By Femtech Insider Investment, News, Reproductive Health February 13, 2023 ShareTwitterFacebookPinterest-circled Twentyeight Health Adds $8.3M in Pre-Series A Funding to Finance National Expansion in the US
By Femtech Insider Ecosystem, Menopause, News February 13, 2023 ShareTwitterFacebookPinterest-circled Menopause Awareness: Astellas Pharma Buys Superbowl Commercial Spot to Ask “What’s VMS?”
By Femtech Insider Fertility, News, Pregnancy February 13, 2023 ShareTwitterFacebookPinterest-circled Wingwomen Pivots from Peer Support to Coaching Platform for Women with Preexisting Conditions Trying to Conceive
